Related Articles

• HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
• Correlation between topoisomerase-IIα gene amplification and protein expression in HER-2 amplified breast cancer
• Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer
• Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: Comparative study of immunohistochemistry and fluorescent in situ hybridization
• Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: A comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization